T-Cell mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ.
The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index.
Abstract
Bone resorption is regulated by the immune system, where T-cell expression of RANKL (receptor activator of nuclear factor (NF)-kappaB ligand), a member of the tumour-necrosis factor family that is essential for osteoclastogenesis, may contribute to pathological conditions, such as autoimmune arthritis. However, whether activated T cells maintain bone homeostasis by counterbalancing the action of RANKL remains unknown. Here we show that T-cell production of interferon (IFN)-gamma strongly suppresses osteoclastogenesis by interfering with the RANKL-RANK signalling pathway. IFN-gamma induces rapid degradation of the RANK adapter protein, TRAF6 (tumour necrosis factor receptor-associated factor 6), which results in strong inhibition of the RANKL-induced activation of the transcription factor NF-kappaB and JNK. This inhibition of osteoclastogenesis is rescued by overexpressing TRAF6 in precursor cells, which indicates that TRAF6 is the target critical for the IFN-gamma action. Furthermore, we provide evidence that the accelerated degradation of TRAF6 requires both its ubiquitination, which is initiated by RANKL, and IFN-gamma-induced activation of the ubiquitin-proteasome system. Our study shows that there is cross-talk between the tumour necrosis factor and IFN families of cytokines, through which IFN-gamma provides a negative link between T-cell activation and bone resorption. Our results may offer a therapeutic approach to treat the inflammation-induced tissue breakdown.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Synovial cells isolated from rheumatoid joints have been found to express RANKL, RANK, and OPG (90, 412-415).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [415]
Citations
Cites
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,336
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Immune Response in Mice that Lack the Interferon-γ Receptor
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilček, J., Zinkernagel, R. M., & Aguet, M. (1993) · Science · doi:10.1126/science.8456301 · Cited by 1,548
The Proteasome: Paradigm of a Self-Compartmentalizing Protease
Baumeister, W., Walz, J., Zühl, F., & Seemüller, E. (1998) · Cell · doi:10.1016/s0092-8674(00)80929-0 · Cited by 1,494
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
Lomaga, M. A., Yeh, W.-C., Sarosi, I., Duncan, G. S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,267
Matsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T., Watanabe, N., Kündig, T. M., Amakawa, R., Kishihara, K., Wakeham, A., et al. (1993) · Cell · doi:10.1016/s0092-8674(05)80086-8 · Cited by 649
Self-citation
Research works printed but not linked: 2
- Takayanagi, H. et al. Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum. 43, 259–269 (2000). · doi:10.1002/1529-0131(200002)43:2<259::aid-anr4>3.0.co;2-w
- Gravallese, E. M. et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 43, 250–258 (2000). · doi:10.1002/1529-0131(200002)43:2<250::aid-anr3>3.0.co;2-p
Cited by
Items 301–400 of 1,001
Interfering with bone remodelling
Alliston, T. N., & Derynck, R. (2002) · Nature · doi:10.1038/416686a · Cited by 104
New immune connections in osteoclast formation
Takayanagi, H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05303.x · Cited by 97
Self-citationT Cells Are Required for Orthodontic Tooth Movement
Yan, Y., Liu, F., Kou, X., Liu, D., Yang, R., Wang, X., Song, Y., He, D., Gan, Y.-H., & Zhou, Y. (2015) · Journal of Dental Research · doi:10.1177/0022034515595003 · Cited by 95
RANKL and RANK as novel therapeutic targets for arthritis
Nakashima, T., & Penninger, J. M. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200305000-00016 · Cited by 92
New insights into IFN-γ in rheumatoid arthritis: role in the era of JAK inhibitors
Kato, M. (2020) · Immunological Medicine · doi:10.1080/25785826.2020.1751908 · Cited by 92
Murine Osteoclast Formation and Function: Differential Regulation by Humoral Agents
Fuller, K., Kirstein, B., & Chambers, T. J. (2005) · Endocrinology · doi:10.1210/en.2005-1340 · Cited by 97
Weitzmann, M. N., & Pacifici, R. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.068 · Cited by 98
Osteoclasts and the immune system
Nakashima, T., & Takayanagi, H. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0089-z · Cited by 94
Self-citationRahman, M. M., Bhattacharya, A., & Fernandes, G. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600151-jlr200 · Cited by 95
Inhibition of p38 Mitogen-Activated Protein Kinase Prevents Inflammatory Bone Destruction
Mbalaviele, G., Anderson, G. D., Jones, A., Ciechi, P. D., Settle, S., Mnich, S., Thiede, M. A., Abu‐Amer, Y., Portanova, J. P., & Monahan, J. B. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.100362 · Cited by 97
Dar, H. Y., Singh, A., Shukla, P., Anupam, R., Mondal, R. K., Mishra, P. K., & Srivastava, R. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-20896-y · Cited by 89
Osteoimmunology: The Regulatory Roles of T Lymphocytes in Osteoporosis
Zhang, W., Dang, K., Huai, Y., & Qian, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00465 · Cited by 87
Kalliolias, G. D., Zhao, B., Triantafyllopoulou, A., Park‐Min, K., & Ivashkiv, L. B. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27200 · Cited by 87
Komatsu, N., & Takayanagi, H. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394299-9.00002-3 · Cited by 103
Self-citationTunyogi-Csapó, M., Kis‐Tóth, K., Radács, M., Farkas, B., Jacobs, J. J., Finnegan, A., Mikecz, K., & Glant, T. T. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23653 · Cited by 94
Interleukin-32 Promotes Osteoclast Differentiation but Not Osteoclast Activation
Mabilleau, G., & Sabokbar, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004173 · Cited by 92
Kamiya, S., Nakamura, C., Fukawa, T., Ono, K., Ohwaki, T., Yoshimoto, T., & Wada, S. (2007) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-007-0766-8 · Cited by 93
Ishida, A., Fujita, N., Kitazawa, R., & Tsuruo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111093200 · Cited by 87
From bone biology to clinical outcome: state of the art and future perspectives
Schett, G. A., Saag, K. G., & Bijlsma, J. W. J. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.135061 · Cited by 86
Adiponectin inhibits induction of TNF‐α/RANKL‐stimulated NFATc1 via the AMPK signaling
Yamaguchi, N., Kukita, T., Li, Y.-J., Kamio, N., Fukumoto, S., Nonaka, K., Ninomiya, Y., Hanazawa, S., & Yamashita, Y. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.12.037 · Cited by 85
Prostaglandin E2 Strongly Inhibits Human Osteoclast Formation
Take, I., Kobayashi, Y., Yamamoto, Y., Tsuboi, H., Ochi, T., Uematsu, S., Okafuji, N., Kurihara, S., Udagawa, N., & Takahashi, N. (2005) · Endocrinology · doi:10.1210/en.2005-0451 · Cited by 85
Inactivation of Glycogen Synthase Kinase-3β Is Required for Osteoclast Differentiation
Jang, H. D., Shin, J. H., Park, D. R., Hong, J. H., Yoon, K., Ko, R., Ko, C.-Y., Kim, H.-S., Jeong, D., Kim, N., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.256768 · Cited by 83
Nagata, N., Kitaura, H., Yoshida, N., & Nakayama, K. (2003) · Bone · doi:10.1016/s8756-3282(03)00213-8 · Cited by 89
Selenoprotein W ensures physiological bone remodeling by preventing hyperactivity of osteoclasts
Kim, H., Lee, K., Kim, J., Kim, M. Y., Kim, J.-R., Lee, H., Chung, Y. W., Shin, H.-I., Kim, T. S., Park, E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22565-7 · Cited by 87
Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis
Rahman, M. M., Bhattacharya, A., Banu, J., Kang, J. X., & Fernandes, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00649.x · Cited by 88
Breaking old paradigms: Th17 cells in autoimmune arthritis
Peck, A., & Mellins, E. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.03.522 · Cited by 94
Yang, S., Mayton, L., Wu, B., Goater, J. J., Schwarz, E. M., & Wooley, P. H. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10527 · Cited by 82
Paracrine regulation of osteoclast formation and activity: milestones in discovery.
Martin, T. (2004) · PubMed · Cited by 92
Qiao, Y., Kang, K., Giannopoulou, E., Fang, C., & Ivashkiv, L. B. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.051 · Cited by 81
Bone mineral density in people living with HIV: a narrative review of the literature
Kruger, M., & Nell, T. A. (2017) · AIDS Research and Therapy · doi:10.1186/s12981-017-0162-y · Cited by 97
Osteoimmunology drives dental implant osseointegration: A new paradigm for implant dentistry
Amengual‐Peñafiel, L., Córdova, L. A., Jara-Sepúlveda, M., Brañes-Aroca, M., Carrasco, F. M., & Cartes‐Velásquez, R. (2021) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2021.01.001 · Cited by 96
Gasper-Smith, N., Petty, C. C., Schrum, L. W., Marriott, I., & Bost, K. L. (2002) · Infection and Immunity · doi:10.1128/iai.70.8.4075-4082.2002 · Cited by 86
Zupan, J., Komadina, R., & Marc, J. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-28 · Cited by 81
Tan, E. M., Li, L., Indran, I. R., Chew, N., & Yong, E. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3031 · Cited by 85
New aspects of IFN‐α/β signalling in immunity, oncogenesis and bone metabolism
Takaoka, A., & Taniguchi, T. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01455.x · Cited by 81
Self-citationProminent Bone Loss Mediated by RANKL and IL-17 Produced by CD4+ T Cells in TallyHo/JngJ Mice
Won, H. Y., Lee, J.-A., Park, Z. S., Song, J. S., Kim, H. Y., Jang, S.-M., Yoo, S.-E., Rhee, Y., Hwang, E. S., & Bae, M. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018168 · Cited by 91
Adenosine A 1 receptors (A 1 Rs) play a critical role in osteoclast formation and function
Kara, F. M., Chitu, V., Sloane, J., Axelrod, M., Fredholm, B. B., Stanley, E. R., & Cronstein, B. N. (2010) · The FASEB Journal · doi:10.1096/fj.09-147447 · Cited by 80
Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption
Boyce, B. F., Li, J., Xing, L., & Yao, Z. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02263 · Cited by 86
Ubiquitin Chains in the Ladder of MAPK Signaling
Laine, A. M., & Ronai, Z. A. (2005) · Science s STKE · doi:10.1126/stke.2812005re5 · Cited by 89
Somayaji, S. N., Ritchie, S., Sahraei, M., Marriott, I., & Hudson, M. C. (2008) · Infection and Immunity · doi:10.1128/iai.00228-08 · Cited by 83
Teng, Y.-T. A., Mahamed, D., & Singh, B. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3453-3461.2005 · Cited by 77
SQSTM1 and Paget?s Disease of Bone
Layfield, R., & Hocking, L. J. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0041-0 · Cited by 76
Regulatory T cell phenotype and anti-osteoclastogenic function in experimental periodontitis
Álvarez, C., Suliman, S., Almarhoumi, R., Vega, M. E., Rojas, C., Monasterio, G., Galindo, M. A., Vernal, R., & Kantarcı, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-76038-w · Cited by 82
Osteoimmunology: The Crosstalk between T Cells, B Cells, and Osteoclasts in Rheumatoid Arthritis
Yang, M., & Zhu, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052688 · Cited by 97
Tang, Y., Xie, H., Chen, J., Geng, L., Chen, H., Li, X., Hou, Y., Lu, L., Shi, S., Zeng, X., et al. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0226 · Cited by 90
Inflammation-Induced Bone Loss: Can it Be Prevented?
Romas, E., & Gillespie, M. T. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.07.004 · Cited by 87
Urushibara, M., Takayanagi, H., Koga, T., Kim, S., Isobe, M., Morishita, Y., Nakagawa, T., Loeffler, M. L., Kodama, T., Kurosawa, H., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20206 · Cited by 78
Self-citationTerashima, A., & Takayanagi, H. (2018) · Calcified Tissue International · doi:10.1007/s00223-018-0417-1 · Cited by 81
Self-citationMicroenvironment-targeted strategy steers advanced bone regeneration
Hao, S., Wang, M., Yin, Z., Jing, Y., Bai, L., & Su, J. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100741 · Cited by 75
Yip, K. H. M., Feng, H., Pavlos, N. J., Zheng, M., & Xu, J. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050960 · Cited by 80
Kohara, H., Kitaura, H., Fujimura, Y., Yoshimatsu, M., Morita, Y., Eguchi, T., Masuyama, R., & Yoshida, N. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.02.017 · Cited by 75
Expression of membrane-bound and soluble receptor activator of NF-κB ligand (RANKL) in human T cells
Kanamaru, F., Iwai, H., Ikeda, T., Nakajima, A., Ishikawa, I., & Azuma, M. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.05.010 · Cited by 90
Li, B., Wang, P., Jiao, J., Wei, H., Xu, W., & Zhou, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.824117 · Cited by 98
ETS1 governs pathological tissue-remodeling programs in disease-associated fibroblasts
Yan, M., Komatsu, N., Muro, R., Huynh, N. C., Tomofuji, Y., Okada, Y., Suzuki, H. I., Takaba, H., Kitazawa, R., Kitazawa, S., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01285-0 · Cited by 81
Self-citationKotake, S., Yago, T., Kawamoto, M., & Nanke, Y. (2011) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-011-0321-5 · Cited by 78
Furukawa, M., Takaishi, H., Takito, J., Yoda, M., Sakai, S., Hikata, T., Hakozaki, A., Uchikawa, S., Matsumoto, M., Chiba, K., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802091 · Cited by 82
Osteoclasts—Key Players in Skeletal Health and Disease
Novack, D. V., & Mbalaviele, G. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0011-2015 · Cited by 86
Tesei, D., Jewczynko, A., Lynch, A., & Urbaniak, C. (2022) · Life · doi:10.3390/life12040495 · Cited by 88
Therapy Insight: osteoporosis and osteonecrosis in systemic lupus erythematosus
Lane, N. E. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0298 · Cited by 72
Seshasayee, D., Wang, H., Lee, W. P., Gribling, P., Ross, J., Van Bruggen, N., Carano, R., & Grewal, I. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403968200 · Cited by 73
Immunological pathogenesis of main age-related diseases and frailty: Role of immunosenescence
Lang, P.-O., Mitchell, W. A., Lapenna, A., Pitts, D. G., & Aspinall, R. (2010) · European Geriatric Medicine · doi:10.1016/j.eurger.2010.01.010 · Cited by 79
Rakshit, D. S., Ly, K., Sengupta, T. K., Nestor, B. J., Sculco, T. P., Ivashkiv, L. B., & Purdue, P. E. (2006) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.e.00711 · Cited by 72
Senile osteoporosis: Is it an immune-mediated disease?
Martinis, M. D., Benedetto, M. C. D., Mengoli, L. P., & Ginaldi, L. (2006) · Inflammation Research · doi:10.1007/s00011-006-6034-x · Cited by 75
Marques, E. A., Mota, J. A. P. S., Viana, J. L., Tuna, D., Figueiredo, P., Guimarães, J. T., & Carvalho, J. (2013) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2013.03.014 · Cited by 87
Osteoclastic differentiation and function regulated by old and new pathways
Blair, H. C., & Zaidi, M. (2006) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-006-9010-4 · Cited by 82
A possible role for TSLP in inflammatory arthritis
Koyama, K., Ozawa, T., Hatsushika, K., Ando, T., Takano, S., Wako, M., Suenaga, F., Ohnuma, Y., Ohba, T., Katoh, R., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.081 · Cited by 81
Th17 cells can provide B cell help in autoantibody induced arthritis
Hickman‐Brecks, C. L., Racz, J. L., Meyer, D. M., LaBranche, T. P., & Allen, P. M. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.10.007 · Cited by 73
Stańdo-Retecka, M., Piątek, P., Namiecińska, M., Lewkowicz, P., & Lewkowicz, N. (2020) · Nutrients · doi:10.3390/nu12092614 · Cited by 82
The dynamic interplay between osteoclasts and the immune system
Nakashima, T., & Takayanagi, H. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.04.004 · Cited by 78
Self-citationPre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease
Moschen, A. R., Geiger, S., Gerner, R. R., & Tilg, H. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.06.012 · Cited by 77
Bone inflammation and altered gene expression with type I diabetes early onset
Motyl, K. J., Boțolin, S., Irwin, R., Appledorn, D. M., Kadakia, T., Amalfitano, A., Schwartz, R. C., & McCabe, L. R. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21626 · Cited by 71
Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis
Blin‐Wakkach, C., Wakkach, A., Sexton, P. M., Rochet, N., & Carle, G. F. (2004) · Leukemia · doi:10.1038/sj.leu.2403449 · Cited by 78
Lubberts, E., Oppers‐Walgreen, B., Pettit, A. R., Van Den Bersselaar, L., Joosten, L. A. B., Goldring, S. R., Gravallese, E. M., & Van Den Berg, W. B. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10607 · Cited by 71
Wintges, K., Beil, F. T., Albers, J., Jeschke, A., Schweizer, M., Claass, B., Tiegs, G., Amling, M., & Schinke, T. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1937 · Cited by 73
MicroRNA-194 promotes osteoblast differentiation via downregulating STAT1
Li, J., He, X., Wei, W., & Zhou, X. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.059 · Cited by 71
Innate and adaptive immunity of periodontal disease. From etiology to alveolar bone loss
Becerra‐Ruiz, J. S., Velázquez, C. G., Martínez–Esquivias, F., Martínez‐Pérez, L. A., & Guzmán‐Flores, J. M. (2021) · Oral Diseases · doi:10.1111/odi.13884 · Cited by 89
Mo, L., Ma, C., Wang, Z., Li, J., He, W., Niu, W., Chen, Z., Zhou, C., & Liu, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.950030 · Cited by 78
T-Cells Mediate an Inhibitory Effect of Interleukin-4 on Osteoclastogenesis
Mirosavljevic, D., Quinn, J. M. W., Elliott, J., Horwood, N. J., Martin, T. J., & Gillespie, M. T. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.984 · Cited by 77
Stone, B., Dockrell, D. H., Bowman, C., & McCloskey, E. V. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.07.029 · Cited by 79
Osteoclasts in the Inflammatory Arthritis: Implications for Pathologic Osteolysis
Jung, Y., Kang, Y. M., & Han, S. W. (2019) · Immune Network · doi:10.4110/in.2019.19.e2 · Cited by 77
Signalling in osteoclasts and the role of Fos/AP1 proteins
Wagner, E. F., & Matsuo, K. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.suppl_2.ii83 · Cited by 80
Gao, B., Calhoun, K. H., & Fang, D. (2006) · Arthritis Research & Therapy · doi:10.1186/ar2081 · Cited by 70
Panagopoulos, P. K., & Lambrou, G. Ι. (2018) · PubMed Central · Cited by 84
Role of nuclear factor κb in synovial inflammation
Müller‐Ladner, U., Gay, R. E., & Gay, S. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0066-1 · Cited by 66
Ahern, D., & Brennan, F. (2011) · Immunology Letters · doi:10.1016/j.imlet.2010.11.001 · Cited by 70
Life-Long Caloric Restriction Reveals Biphasic and Dimorphic Effects on Bone Metabolism in Rodents
Tatsumi, S., Ito, M., Asaba, Y., Tsutsumi, K., & Ikeda, K. (2008) · Endocrinology · doi:10.1210/en.2007-1089 · Cited by 67
Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1
Tai, Y., Cho, S., & Anderson, K. C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01822 · Cited by 70
Postmenopausal osteoporosis, T cells, and immune dysfunction
Teitelbaum, S. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407335101 · Cited by 68
Pathogenesis of Osteopenia/Osteoporosis Induced by Highly Active Anti‐Retroviral Therapy for AIDS
Pan, G., Yang, Z., Ballinger, S. W., & McDonald, J. M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.057 · Cited by 73
Huang, W., O'Keefe, R. J., & Schwarz, E. M. (2002) · Arthritis Res Ther · doi:10.1186/ar612 · Cited by 67
Inhibition of STAT1 accelerates bone fracture healing
Tajima, K., Takaishi, H., Takito, J., Tohmonda, T., Yoda, M., Ota, N., Kosaki, N., Matsumoto, M., Ikegami, H., Nakamura, T., et al. (2010) · Journal of Orthopaedic Research® · doi:10.1002/jor.21086 · Cited by 71
Induction of IL-10-producing CD4 + T-cells in Chronic Periodontitis
Kobayashi, R., Kôno, T., Bolerjack, B. A., Fukuyama, Y., Gilbert, R. S., Fujihashi, K., Ruby, J. D., Kataoka, K., Wada, M., Yamamoto, M., et al. (2011) · Journal of Dental Research · doi:10.1177/0022034510397838 · Cited by 78
Nagy, E., Yang, L., Martínez‐Martínez, E., Body, S. C., Schlotter, F., Creager, M. D., Assmann, A., Khabbaz, K. R., Libby, P., Hansson, G. K., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.02.012 · Cited by 71
Pyroptosis in Osteoblasts: A Novel Hypothesis Underlying the Pathogenesis of Osteoporosis
Tao, Z., Wang, J., Wen, K., Yao, R.-Q., Da, W., Zhou, S., Meng, Y., Qiu, S., Yang, K., Zhu, Y., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.548812 · Cited by 75
Novel insights into the coupling of osteoclasts and resorption to bone formation
Durdan, M., Azaria, R. D., & Weivoda, M. M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.10.008 · Cited by 76
HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture
Ofotokun, I., & Weitzmann, M. N. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833f48d6 · Cited by 70
Oduro, K. A., Liu, F., Tan, Q., Kim, C.-K., Lubman, O., Fremont, D., Mills, J. C., & Choi, K. (2012) · Blood · doi:10.1182/blood-2011-11-391342 · Cited by 65
Probiotics as oral health biotherapeutics
Saha, S., Tomaro-Duchesneau, C., Tabrizian, M., & Prakash, S. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.693474 · Cited by 65
Th17 and Th1 Lymphocytes Are Correlated with Chronic Periodontitis
Chen, X.-T., Chen, L., Tan, J., Shi, D.-H., Ke, T., & Lei, L. (2016) · Immunological Investigations · doi:10.3109/08820139.2016.1138967 · Cited by 65
Kim, H., Walsh, M. C., Takegahara, N., Middleton, S. A., Shin, H., Kim, J., & Choi, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-00139-2 · Cited by 65
Metadata
- Authors
- Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., Nakamura, K., & Taniguchi, T.
- Affiliations
- The University of Tokyo (JP)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Corresponding author
- Taniguchi, Tadatsugu
- ORCID
- Venue
- Nature
- Published
- 2000-11
- Volume
- 408
- Issue
- 6812
- Pages
- 600-605
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1639854378
- Cited by
- 1,358
- References
- 31
- Citations by year
- 2026: 34 · 2025: 41 · 2024: 45 · 2023: 47 · 2022: 51 · 2021: 68 · 2020: 66 · 2019: 45 · 2018: 48 · 2017: 51 · 2016: 47 · 2015: 46 · 2014: 41 · 2013: 56 · 2012: 50
- FWCI
- 15.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Japan Society for the Promotion of Science
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- osteoclastogenesis, RANKL, interferon-gamma, T cells, TRAF6, NF-κB, JNK, ubiquitination, ubiquitin-proteasome system, bone resorption, bone homeostasis, autoimmune arthritis
- MeSH terms
- Animals, Arthritis, Autoantigens, Autoimmune Diseases, Bone Marrow Cells, Bone Resorption, Carrier Proteins, Cells, Cultured, Cysteine Endopeptidases, Glycoproteins, Interferon-gamma, Lymphocyte Activation, Macrophages, Membrane Glycoproteins, Mice, Inbred C57BL, Multienzyme Complexes, Osteoclasts, Proteins, T-Lymphocytes, Ubiquitins, Signal Transduction, NF-kappa B, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Coculture Techniques, Mitogen-Activated Protein Kinase Kinases, Proteasome Endopeptidase Complex, TNF Receptor-Associated Factor 6, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, Mice, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.